Short-Term Outcomes After COVID-19-Related Treatment Interruption Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Bevacizumab
Davide Allegrini,1 Raffaele Raimondi,2 Giovanni Montesano,3 Alfredo Borgia,2 Tania Sorrentino,2 Panagiotis Tsoutsanis,2 Mario R Romano1,2 1Eye Center, Humanitas, Bergamo, Italy; 2Department of Biomedical Sciences, Humanitas University, Milano, Italy; 3University of London - Optometry and Visual Scie...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2021-10-01
|
| Series: | Clinical Ophthalmology |
| Subjects: | |
| Online Access: | https://www.dovepress.com/short-term-outcomes-after-covid-19-related-treatment-interruption-amon-peer-reviewed-fulltext-article-OPTH |
| _version_ | 1818845251787292672 |
|---|---|
| author | Allegrini D Raimondi R Montesano G Borgia A Sorrentino T Tsoutsanis P Romano MR |
| author_facet | Allegrini D Raimondi R Montesano G Borgia A Sorrentino T Tsoutsanis P Romano MR |
| author_sort | Allegrini D |
| collection | DOAJ |
| description | Davide Allegrini,1 Raffaele Raimondi,2 Giovanni Montesano,3 Alfredo Borgia,2 Tania Sorrentino,2 Panagiotis Tsoutsanis,2 Mario R Romano1,2 1Eye Center, Humanitas, Bergamo, Italy; 2Department of Biomedical Sciences, Humanitas University, Milano, Italy; 3University of London - Optometry and Visual Sciences, London, UKCorrespondence: Raffaele RaimondiDepartment of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, Milano, ItalyTel +39 02 8224 7100Email raffor9@gmail.comPurpose: To assess outcomes and recovery strategy of patients undergoing intravitreal injections for exudative age-related macular degeneration who experienced COVID-19 related interruption in treatment during complete lockdown.Methods: This was a retrospective, observational case study. We used a mixed effect model with random intercepts to evaluate best corrected visual acuity (BCVA) accounting for measured central macular thickness (CMT) and individual variability of each eye. Furthermore, we analysed measures of the pigmented epithelium detachment as well as presence of subretinal fluid and intraretinal cysts.Results: We included 39 patients and we found a significant reduction in the BCVA between the pre- and post-lockdown controlling for CMT. There was no significant difference in pigmented epithelium detachment and in presence of subretinal fluid and intraretinal cysts.Conclusion: We detected a significant loss in visual function. The magnitude of the average loss was, however, limited suggesting good efficacy of the recovery strategy.Keywords: IVT interruption, covid-19, intravitreal injection, bevacizumab |
| first_indexed | 2024-12-19T05:26:42Z |
| format | Article |
| id | doaj.art-858c4ff36d404093b285de3b8f33c482 |
| institution | Directory Open Access Journal |
| issn | 1177-5483 |
| language | English |
| last_indexed | 2024-12-19T05:26:42Z |
| publishDate | 2021-10-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Clinical Ophthalmology |
| spelling | doaj.art-858c4ff36d404093b285de3b8f33c4822022-12-21T20:34:21ZengDove Medical PressClinical Ophthalmology1177-54832021-10-01Volume 154073407969597Short-Term Outcomes After COVID-19-Related Treatment Interruption Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal BevacizumabAllegrini DRaimondi RMontesano GBorgia ASorrentino TTsoutsanis PRomano MRDavide Allegrini,1 Raffaele Raimondi,2 Giovanni Montesano,3 Alfredo Borgia,2 Tania Sorrentino,2 Panagiotis Tsoutsanis,2 Mario R Romano1,2 1Eye Center, Humanitas, Bergamo, Italy; 2Department of Biomedical Sciences, Humanitas University, Milano, Italy; 3University of London - Optometry and Visual Sciences, London, UKCorrespondence: Raffaele RaimondiDepartment of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, Milano, ItalyTel +39 02 8224 7100Email raffor9@gmail.comPurpose: To assess outcomes and recovery strategy of patients undergoing intravitreal injections for exudative age-related macular degeneration who experienced COVID-19 related interruption in treatment during complete lockdown.Methods: This was a retrospective, observational case study. We used a mixed effect model with random intercepts to evaluate best corrected visual acuity (BCVA) accounting for measured central macular thickness (CMT) and individual variability of each eye. Furthermore, we analysed measures of the pigmented epithelium detachment as well as presence of subretinal fluid and intraretinal cysts.Results: We included 39 patients and we found a significant reduction in the BCVA between the pre- and post-lockdown controlling for CMT. There was no significant difference in pigmented epithelium detachment and in presence of subretinal fluid and intraretinal cysts.Conclusion: We detected a significant loss in visual function. The magnitude of the average loss was, however, limited suggesting good efficacy of the recovery strategy.Keywords: IVT interruption, covid-19, intravitreal injection, bevacizumabhttps://www.dovepress.com/short-term-outcomes-after-covid-19-related-treatment-interruption-amon-peer-reviewed-fulltext-article-OPTHivt interruptioncovid-19intravitreal injectionbevacizumab |
| spellingShingle | Allegrini D Raimondi R Montesano G Borgia A Sorrentino T Tsoutsanis P Romano MR Short-Term Outcomes After COVID-19-Related Treatment Interruption Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Bevacizumab Clinical Ophthalmology ivt interruption covid-19 intravitreal injection bevacizumab |
| title | Short-Term Outcomes After COVID-19-Related Treatment Interruption Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Bevacizumab |
| title_full | Short-Term Outcomes After COVID-19-Related Treatment Interruption Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Bevacizumab |
| title_fullStr | Short-Term Outcomes After COVID-19-Related Treatment Interruption Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Bevacizumab |
| title_full_unstemmed | Short-Term Outcomes After COVID-19-Related Treatment Interruption Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Bevacizumab |
| title_short | Short-Term Outcomes After COVID-19-Related Treatment Interruption Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Bevacizumab |
| title_sort | short term outcomes after covid 19 related treatment interruption among patients with neovascular age related macular degeneration receiving intravitreal bevacizumab |
| topic | ivt interruption covid-19 intravitreal injection bevacizumab |
| url | https://www.dovepress.com/short-term-outcomes-after-covid-19-related-treatment-interruption-amon-peer-reviewed-fulltext-article-OPTH |
| work_keys_str_mv | AT allegrinid shorttermoutcomesaftercovid19relatedtreatmentinterruptionamongpatientswithneovascularagerelatedmaculardegenerationreceivingintravitrealbevacizumab AT raimondir shorttermoutcomesaftercovid19relatedtreatmentinterruptionamongpatientswithneovascularagerelatedmaculardegenerationreceivingintravitrealbevacizumab AT montesanog shorttermoutcomesaftercovid19relatedtreatmentinterruptionamongpatientswithneovascularagerelatedmaculardegenerationreceivingintravitrealbevacizumab AT borgiaa shorttermoutcomesaftercovid19relatedtreatmentinterruptionamongpatientswithneovascularagerelatedmaculardegenerationreceivingintravitrealbevacizumab AT sorrentinot shorttermoutcomesaftercovid19relatedtreatmentinterruptionamongpatientswithneovascularagerelatedmaculardegenerationreceivingintravitrealbevacizumab AT tsoutsanisp shorttermoutcomesaftercovid19relatedtreatmentinterruptionamongpatientswithneovascularagerelatedmaculardegenerationreceivingintravitrealbevacizumab AT romanomr shorttermoutcomesaftercovid19relatedtreatmentinterruptionamongpatientswithneovascularagerelatedmaculardegenerationreceivingintravitrealbevacizumab |